Zobrazeno 1 - 10
of 21
pro vyhledávání: '"James, Mansi"'
Autor:
Stephanie Kalb, John Diaz-Decaro, Harout Tossonian, Andrew Natenshon, Lori Panther, James Mansi, Laura Gibson
Publikováno v:
International Journal of Neonatal Screening, Vol 9, Iss 3, p 37 (2023)
Cytomegalovirus (CMV) infection during pregnancy may result in long-term health problems for children with congenital CMV (cCMV). Currently, no prevention or treatment interventions are approved by the Food and Drug Administration for a cCMV indicati
Externí odkaz:
https://doaj.org/article/0831690695eb4bd49e6ec3ac37cbbf09
Autor:
Katherine E, Mues, Brenna, Kirk, Deesha A, Patel, Alice, Gelman, L Scott, Chavers, Carla A, Talarico, Daina B, Esposito, David, Martin, James, Mansi, Xing, Chen, Nicolle M, Gatto, Nicolas, Van de Velde
Publikováno v:
Vaccine. 40:6730-6739
Head-to-head studies comparing COVID-19 mRNA vaccine effectiveness in immunocompromised individuals, who are vulnerable to severe disease are lacking, as large sample sizes are required to make meaningful inferences.This observational comparative eff
Autor:
Gibson, Stephanie Kalb, John Diaz-Decaro, Harout Tossonian, Andrew Natenshon, Lori Panther, James Mansi, Laura
Publikováno v:
International Journal of Neonatal Screening; Volume 9; Issue 3; Pages: 37
Cytomegalovirus (CMV) infection during pregnancy may result in long-term health problems for children with congenital CMV (cCMV). Currently, no prevention or treatment interventions are approved by the Food and Drug Administration for a cCMV indicati
Autor:
Erin Roberts, Philip O. Buck, Renae L. Smith-Ray, Nicolas Van de Velde, Tanya Singh, James Mansi, Amy Shah, Michael Taitel
Publikováno v:
Vaccine.
Publikováno v:
Vaccines, Vol 9, Iss 4, p 312 (2021)
Older adults (≥65 years) are at elevated risk of influenza-related morbidity and mortality. Many developed countries do not achieve the World Health Organization influenza immunization target of 75% in people ≥65 years. We aimed to determine whet
Externí odkaz:
https://doaj.org/article/01ec2952d2cc41a896a8e50ae5ae8797
Autor:
James, Mansi1,2 (AUTHOR), Anvari, Sara1,2 (AUTHOR), Anagnostou, Aikaterini1,2 (AUTHOR) aikaterini.anagnostou@bcm.edu, Peters, Rachel (AUTHOR)
Publikováno v:
Pediatric Allergy & Immunology. Jul2020, Vol. 31 Issue 5, p589-592. 4p.
Autor:
Katherine E. Mues, Brenna Kirk, Deesha A. Patel, Alice Gelman, Scott Chavers, Carla Talarico, Daina B. Esposito, David Martin, James Mansi, Xing Chen, Nicolle M. Gatto, Nicolas Van de Velde
IntroductionHead-to-head studies comparing COVID-19 mRNA vaccine effectiveness in immunocompromised individuals, who are vulnerable to severe disease are lacking, as large sample sizes are required to make meaningful inferences.MethodsThis observatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7784b27ab8e104c6a3517f8a27741e60
https://doi.org/10.1101/2022.05.13.22274960
https://doi.org/10.1101/2022.05.13.22274960
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joseph, Michelle, Chew, Wai-Tim, Seeborg, Filiz, Satter, Lisa Forbes, Anvari, Sara, Chinn, Ivan K., Davis, Carla M., Gupta, Meera R., Nicholas, Sarah, Noroski, Lenora M., James, Mansi, Deniskin, Roman, Diaz, Veronica C., Lowe, Juliette, Lee, Grace L., Craddock, Megan F., Chan, Audrey J., Rider, Nicholas L.
Publikováno v:
In The Journal of Allergy and Clinical Immunology: In Practice September 2020 8(8):2769-2770
Autor:
Arlene King, Neil Maresky, Scott A. Halperin, Brian J. Ward, Lisa Danzig, Greg Hammond, Simon Dobson, Danuta M. Skowronski, Donald B. Elrick, Bernard Duval, Beth A. Halperin, Gordean Bjornson, James Mansi, David Wortzman, Susan Tamblyn, Elspeth Carnan, Barbara Law, Laszlo Palkonyay, Francoise Bertrand, Pierre Lavigne, David W. Scheifele, Gail Clements, Elaine E. Wang
Publikováno v:
Human Vaccines. 1:140-142
In response to concerns about interactions of academic and public health investigators with industry, the Canadian Association for Immunization Research and Evaluation (CAIRE), in collaboration with six major vaccine manufacturers, developed guidelin